Skip to main content

Bharat Neeti

BHARAT NEETI

Be Ahead With Economy And Policy Updates

Latest News
192x192 - PWA

BHARAT NEETI

Be Ahead With Economy And Policy Updates

Menu
Latest

NATCO Pharma Limited, API unit in Chennai Receives Establishment Inspection Report (EIR) from U.S. FDA

NATCO Pharma Limited, API unit in Chennai Receives Establishment Inspection Report (EIR) from U.S. FDA
(Image Courtesy: Natco Pharma Ltd.)
WhatsApp
Facebook
Copy link
URL has been copied successfully!
Hyderabad:  NATCO Pharma Limited (BSE: 524816 and NSE: NATCOPHARM) (“NATCO”) hereby informs you that the U.S. Food and Drug Administration (FDA) had conducted an inspection at the Active Pharmaceutical Ingredient Division located in Manali, Chennai from November 17th – November 21st, 2025. The Company received seven (7) observation in the Form-483.

We hereby notify that the Company has received the EIR (Establishment Inspection Report) from the USFDA on the classification of the above-referred inspection as Voluntary Action Indicated (VAI).

facebookShare on Facebook
TwitterPost on X

Leave a Reply

Your email address will not be published. Required fields are marked *

You are warmly welcomed to India’s first On-Demand News Platform. We are dedicated to fostering a democracy that encourage diverse opinions and are committed to publishing news for all segments of the society. If you believe certain issues or news stories are overlooked by mainstream media, please write to us. We will ensure your news is published on our platform. Your support would be greatly appreciated if you could provide any relevant facts, images, or videos related to your issue.

Contact Form Demo

Newsletter

ad

Recent News

Follow Us

Facebook Twitter Youtube Instagram

Related News